Could stem cells offer a lifeline for End-Stage liver patients?
NCT ID NCT06167473
First seen Apr 19, 2026 · Last updated May 08, 2026 · Updated 2 times
Summary
This study tested whether umbilical cord stem cells given through a vein could help people with end-stage liver disease. 22 adults received different doses to see if it improved survival and liver function. The goal was to find a safer, more available alternative to liver transplants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE LIVER DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, 110840, China
Conditions
Explore the condition pages connected to this study.